Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Sulfoximide, also known as sulfilimine or S-oxide, is a chiral auxiliary used in asymmetric synthesis, particularly in decarboxylative Claisen rearrangements (dCr), where it serves as a sulfone surrogate to achieve high diastereoselectivity. Its stereochemical influence is explained by a pseudochair transition-state model, and modifications such as electron-withdrawing groups can further optimize selectivity and reaction conditions.

14616-60-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 14616-60-5 Structure
  • Basic information

    1. Product Name: Sulfoximide
    2. Synonyms: Sulfilimine S-oxide;Sulfoximide;Sulfoximine
    3. CAS NO:14616-60-5
    4. Molecular Formula: H3N O S
    5. Molecular Weight: 63.08
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 14616-60-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Sulfoximide(CAS DataBase Reference)
    10. NIST Chemistry Reference: Sulfoximide(14616-60-5)
    11. EPA Substance Registry System: Sulfoximide(14616-60-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 14616-60-5(Hazardous Substances Data)

14616-60-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 14616-60-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,6,1 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 14616-60:
(7*1)+(6*4)+(5*6)+(4*1)+(3*6)+(2*6)+(1*0)=95
95 % 10 = 5
So 14616-60-5 is a valid CAS Registry Number.

14616-60-5Upstream product

14616-60-5Downstream Products

14616-60-5Relevant articles and documents

9-Deoxy-9-methylene-16-phenyl-PGF compounds

-

, (2008/06/13)

The present invention relates in part to novel amido, cycloamido, carbonylamido and sulfonylamido derivatives and p-substituted phenyl esters of 9-deoxy-9-methylene-PGF-type compounds. These novel amides produce surprisingly prolonged oral activity as pharmacological agents, as compared to the previously known 9-deoxy-9-methylene-PGF-type compounds. Further, the novel p-substituted phenyl esters provide more stable pharmaceutical formulations as compared to known 9-deoxy-9-methylene-PGF-type esters. Additionally, a novel series of 16-phenyl-9-deoxy-9-methylene-PGF-type compounds in free acid, ester, C-1 alcohol, and C-1 amine form is provided. Such compounds exhibit characteristic prostaglandin-type pharmacological actions.

9-Deoxy-9-methylene-PGF-type amides

-

, (2008/06/13)

The present invention relates in part to novel amido, cycloamido, carbonylamido and sulfonylamido derivatives and p-substituted phenyl esters of 9-deoxy-9-methylene-PGF-type compounds. These novel amides produce surprisingly prolonged oral activity as pharmacological agents, as compared to the previously known 9-deoxy-9-methylene-PGF-type compounds. Further, the novel p-substituted phenyl esters provide more stable pharmaceutical formulations as compared to known 9-deoxy-9-methylene-PGF-type esters. Additionally, a novel series of 16-phenyl-9-deoxy-9-methylene-PGF-type compounds in free acid, ester, C-1 alcohol, and C-1 amine form is provided. Such compounds exhibit characteristic prostaglandin-type pharmacological actions.

Phenothiazine-S-oximide compounds

-

, (2008/06/13)

The present invention is concerned with tricyclic sulphoximides and with the preparation thereof. This family of compounds has been found to possess antihistominic, antitussive, antiinflammatory, sedative, and diuretic properties.

Phenothiazine sulphoximides

-

, (2008/06/13)

The present invention is concerned with novel tricyclic sulphoximides and with the preparation thereof. This family of compounds has been found to possess antihistaminic, antitussive, antiinflammatory, sedative, and diuretic properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14616-60-5